Literature DB >> 11227322

[The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma].

G Rumpold1, M Augustin, I Zschocke, G Strittmatter, W Söllner.   

Abstract

Tumour patients are subject to different degrees of psychosocial distress depending on the course of disease, personality variables and amount of social support available. Often patients do not spontaneously talk about their distress and attending physicians fail to detect it. Therefore, it is important that the presence of distress is ascertained by specific screening instruments so that appropriate supportive measures can be instituted. The Hornheide Questionnaire (HQ) employed for investigating the need for psychosocial support in the case of patients with skin tumours and with tumours in the head and neck region represents such a specific screening instrument. The present study investigates the validity of the HQ on the basis of two representative samples from two different University Clinics for treatment and follow-ups of melanoma patients. With the help of the HQ, 215 patients at the Dermatology Out-patient Unit of the University of Innsbruck and 223 patients at the University of Freiburg were investigated with regard to their subjective experience of distress. The external constructive validity criteria were established on the basis of the Freiburg Questionnaire of Disease-Coping, the questionnaire of social support and Beck's Depression Inventory. There were significant differences between individuals in the severity of distress in different age groups and in patients in different tumour stages. The internal consistency of the HQ and its subscales proved to be satisfactory demarcation from other psychosocial dimensions and an adequate correlation with similar dimensions (depression, depressive illness coping, social support, compliance). The HQ appears to be an economical and valid screening instrument for detecting the need for psychosocial support in melanoma patients in the out-patient follow-up stage.

Entities:  

Mesh:

Year:  2001        PMID: 11227322     DOI: 10.1055/s-2001-10028

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  8 in total

1.  Social support and survival in patients with acute myeloid leukaemia.

Authors:  Martin Pinquart; Klaus Höffken; Rainer K Silbereisen; Ulrich Wedding
Journal:  Support Care Cancer       Date:  2006-09-27       Impact factor: 3.603

2.  Evaluation of the psychological burden during the early disease trajectory in patients with intracranial tumors by the ultra-brief Patient Health Questionnaire for Depression and Anxiety (PHQ-4).

Authors:  Mirjam Renovanz; Sari Soebianto; Helena Tsakmaklis; Naureen Keric; Minou Nadji-Ohl; Manfred Beutel; Florian Ringel; Daniel Wollschläger; Anne-Katrin Hickmann
Journal:  Support Care Cancer       Date:  2019-03-23       Impact factor: 3.603

3.  Physical and psychosocial support requirements of 1,500 patients starting radiotherapy.

Authors:  K Kirchheiner; A Czajka; E Ponocny-Seliger; C Lütgendorf-Caucig; M P Schmid; E Komarek; R Pötter; W Dörr
Journal:  Strahlenther Onkol       Date:  2013-03-29       Impact factor: 3.621

4.  [Psychosocial counseling of skin cancer patients in these times of diagnosis related groups (DRG)].

Authors:  G Strittmatter
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

Review 5.  Symptoms During Outpatient Cancer Treatment and Options for Their Management

Authors:  Mitra Tewes; Freerk Baumann; Martin Teufel; Christoph Ostgathe
Journal:  Dtsch Arztebl Int       Date:  2021-04-30       Impact factor: 5.594

6.  Screening for distress in patients with intracranial tumors during the first 6 months after diagnosis using self-reporting instruments and an expert rating scale (the basic documentation for psycho-oncology short form - PO-Bado SF).

Authors:  Mirjam Renovanz; Helena Tsakmaklis; Sari Soebianto; Isabell Neppel; Minou Nadji-Ohl; Manfred Beutel; Andreas Werner; Florian Ringel; Anne-Katrin Hickmann
Journal:  Oncotarget       Date:  2018-07-24

7.  Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study.

Authors:  Lisa Wiens; Norbert Schäffeler; Thomas Eigentler; Claus Garbe; Andrea Forschner
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

8.  The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank development.

Authors:  Eva-Maria Gamper; Mogens Groenvold; Morten Aa Petersen; Teresa Young; Anna Costantini; Neil Aaronson; Johannes M Giesinger; Verena Meraner; Georg Kemmler; Bernhard Holzner
Journal:  Psychooncology       Date:  2013-11-11       Impact factor: 3.894

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.